+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Precision Medicine Market 2023-2027

  • PDF Icon

    Report

  • 171 Pages
  • May 2023
  • Region: Global
  • TechNavio
  • ID: 5821259
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The precision medicine market is forecasted to grow by USD 54.07 bn during 2022-2027, accelerating at a CAGR of 11.32% during the forecast period. The report on the precision medicine market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of chronic diseases, growing demand for personalized medicine, and advancements in genomics and proteomics.

The precision medicine market is segmented as below:

By Application

  • Oncology
  • CNS
  • Respiratory
  • Immunology
  • Others

By Technology

  • Bioinformatics
  • Gene sequencing
  • Drug discovery
  • Precision molecular diagnostic
  • Big data analytics

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing use of artificial intelligence (AI) and machine learning (ML) in precision medicine as one of the prime reasons driving the precision medicine market growth during the next few years. Also, the integration of genomics and digital health and growing recent developments in precision medicine will lead to sizable demand in the market.

The report on the precision medicine market covers the following areas:

  • Precision medicine market sizing
  • Precision medicine market forecast
  • Precision medicine market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading precision medicine market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biocrates Life Sciences AG, Bristol Myers Squibb Co., Catalent Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., IQVIA Holdings Inc., Johnson and Johnson Services Inc., Lonza Group Ltd., Merck and Co. Inc., Novartis AG, Parexel International Corp., Pfizer Inc., QIAGEN NV, Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Thermo Fisher Scientific Inc. Also, the precision medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global precision medicine market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global precision medicine market 2017 - 2021 ($ billion)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
4.3 Technology Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Technology Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Oncology - Market size and forecast 2022-2027
Exhibit 34: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
6.4 CNS - Market size and forecast 2022-2027
Exhibit 38: Chart on CNS - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on CNS - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on CNS - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on CNS - Year-over-year growth 2022-2027 (%)
6.5 Respiratory - Market size and forecast 2022-2027
Exhibit 42: Chart on Respiratory - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Respiratory - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Respiratory - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Respiratory - Year-over-year growth 2022-2027 (%)
6.6 Immunology - Market size and forecast 2022-2027
Exhibit 46: Chart on Immunology - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on Immunology - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on Immunology - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Immunology - Year-over-year growth 2022-2027 (%)
6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Application
Exhibit 54: Market opportunity by Application ($ billion)
Exhibit 55: Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by Technology
7.1 Market segments
Exhibit 56: Chart on Technology - Market share 2022-2027 (%)
Exhibit 57: Data Table on Technology - Market share 2022-2027 (%)
7.2 Comparison by Technology
Exhibit 58: Chart on Comparison by Technology
Exhibit 59: Data Table on Comparison by Technology
7.3 Bioinformatics - Market size and forecast 2022-2027
Exhibit 60: Chart on Bioinformatics - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Bioinformatics - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Bioinformatics - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Bioinformatics - Year-over-year growth 2022-2027 (%)
7.4 Gene sequencing - Market size and forecast 2022-2027
Exhibit 64: Chart on Gene sequencing - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Data Table on Gene sequencing - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Chart on Gene sequencing - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Gene sequencing - Year-over-year growth 2022-2027 (%)
7.5 Drug discovery - Market size and forecast 2022-2027
Exhibit 68: Chart on Drug discovery - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Chart on Drug discovery - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%)
7.6 Precision molecular diagnostic - Market size and forecast 2022-2027
Exhibit 72: Chart on Precision molecular diagnostic - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Data Table on Precision molecular diagnostic - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Chart on Precision molecular diagnostic - Year-over-year growth 2022-2027 (%)
Exhibit 75: Data Table on Precision molecular diagnostic - Year-over-year growth 2022-2027 (%)
7.7 Big data analytics - Market size and forecast 2022-2027
Exhibit 76: Chart on Big data analytics - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Data Table on Big data analytics - Market size and forecast 2022-2027 ($ billion)
Exhibit 78: Chart on Big data analytics - Year-over-year growth 2022-2027 (%)
Exhibit 79: Data Table on Big data analytics - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Technology
Exhibit 80: Market opportunity by Technology ($ billion)
Exhibit 81: Data Table on Market opportunity by Technology ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 83: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 84: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 85: Chart on Geographic comparison
Exhibit 86: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 87: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 91: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 95: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 99: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 103: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 111: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 112: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 113: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 115: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 116: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 117: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 118: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 119: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 120: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 121: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 122: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 123: Market opportunity By Geographical Landscape ($ billion)
Exhibit 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 125: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 127: Overview on factors of disruption
11.4 Industry risks
Exhibit 128: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 129: Vendors covered
12.2 Market positioning of vendors
Exhibit 130: Matrix on vendor position and classification
12.3 Amgen Inc.
Exhibit 131: Amgen Inc. - Overview
Exhibit 132: Amgen Inc. - Product / Service
Exhibit 133: Amgen Inc. - Key offerings
12.4 AstraZeneca Plc
Exhibit 134: AstraZeneca Plc - Overview
Exhibit 135: AstraZeneca Plc - Product / Service
Exhibit 136: AstraZeneca Plc - Key news
Exhibit 137: AstraZeneca Plc - Key offerings
12.5 Bristol Myers Squibb Co.
Exhibit 138: Bristol Myers Squibb Co. - Overview
Exhibit 139: Bristol Myers Squibb Co. - Product / Service
Exhibit 140: Bristol Myers Squibb Co. - Key news
Exhibit 141: Bristol Myers Squibb Co. - Key offerings
12.6 Catalent Inc.
Exhibit 142: Catalent Inc. - Overview
Exhibit 143: Catalent Inc. - Business segments
Exhibit 144: Catalent Inc. - Key news
Exhibit 145: Catalent Inc. - Key offerings
Exhibit 146: Catalent Inc. - Segment focus
12.7 Eli Lilly and Co.
Exhibit 147: Eli Lilly and Co. - Overview
Exhibit 148: Eli Lilly and Co. - Product / Service
Exhibit 149: Eli Lilly and Co. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
12.9 Gilead Sciences Inc.
Exhibit 155: Gilead Sciences Inc. - Overview
Exhibit 156: Gilead Sciences Inc. - Product / Service
Exhibit 157: Gilead Sciences Inc. - Key news
Exhibit 158: Gilead Sciences Inc. - Key offerings
12.10 Johnson and Johnson Services Inc.
Exhibit 159: Johnson and Johnson Services Inc. - Overview
Exhibit 160: Johnson and Johnson Services Inc. - Business segments
Exhibit 161: Johnson and Johnson Services Inc. - Key news
Exhibit 162: Johnson and Johnson Services Inc. - Key offerings
Exhibit 163: Johnson and Johnson Services Inc. - Segment focus
12.11 Lonza Group Ltd.
Exhibit 164: Lonza Group Ltd. - Overview
Exhibit 165: Lonza Group Ltd. - Business segments
Exhibit 166: Lonza Group Ltd. - Key news
Exhibit 167: Lonza Group Ltd. - Key offerings
Exhibit 168: Lonza Group Ltd. - Segment focus
12.12 Merck and Co. Inc.
Exhibit 169: Merck and Co. Inc. - Overview
Exhibit 170: Merck and Co. Inc. - Business segments
Exhibit 171: Merck and Co. Inc. - Key news
Exhibit 172: Merck and Co. Inc. - Key offerings
Exhibit 173: Merck and Co. Inc. - Segment focus
12.13 Novartis AG
Exhibit 174: Novartis AG - Overview
Exhibit 175: Novartis AG - Business segments
Exhibit 176: Novartis AG - Key offerings
Exhibit 177: Novartis AG - Segment focus
12.14 Pfizer Inc.
Exhibit 178: Pfizer Inc. - Overview
Exhibit 179: Pfizer Inc. - Product / Service
Exhibit 180: Pfizer Inc. - Key news
Exhibit 181: Pfizer Inc. - Key offerings
12.15 Sanofi SA
Exhibit 182: Sanofi SA - Overview
Exhibit 183: Sanofi SA - Business segments
Exhibit 184: Sanofi SA - Key news
Exhibit 185: Sanofi SA - Key offerings
Exhibit 186: Sanofi SA - Segment focus
12.16 Takeda Pharmaceutical Co. Ltd.
Exhibit 187: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 188: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 189: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 190: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Thermo Fisher Scientific Inc.
Exhibit 191: Thermo Fisher Scientific Inc. - Overview
Exhibit 192: Thermo Fisher Scientific Inc. - Business segments
Exhibit 193: Thermo Fisher Scientific Inc. - Key news
Exhibit 194: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 195: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 196: Inclusions checklist
Exhibit 197: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 198: Currency conversion rates for US$
13.4 Research methodology
Exhibit 199: Research methodology
Exhibit 200: Validation techniques employed for market sizing
Exhibit 201: Information sources
13.5 List of abbreviations
Exhibit 202: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Technology
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global precision medicine market 2017 - 2021 ($ billion)
Exhibits 19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
Exhibits 20: Historic Market Size - Technology Segment 2017 - 2021 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Application - Market share 2022-2027 (%)
Exhibits 31: Data Table on Application - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits 35: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits 36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on CNS - Market size and forecast 2022-2027 ($ billion)
Exhibits 39: Data Table on CNS - Market size and forecast 2022-2027 ($ billion)
Exhibits 40: Chart on CNS - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on CNS - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Respiratory - Market size and forecast 2022-2027 ($ billion)
Exhibits 43: Data Table on Respiratory - Market size and forecast 2022-2027 ($ billion)
Exhibits 44: Chart on Respiratory - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Respiratory - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on Immunology - Market size and forecast 2022-2027 ($ billion)
Exhibits 47: Data Table on Immunology - Market size and forecast 2022-2027 ($ billion)
Exhibits 48: Chart on Immunology - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on Immunology - Year-over-year growth 2022-2027 (%)
Exhibits 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 54: Market opportunity by Application ($ billion)
Exhibits 55: Data Table on Market opportunity by Application ($ billion)
Exhibits 56: Chart on Technology - Market share 2022-2027 (%)
Exhibits 57: Data Table on Technology - Market share 2022-2027 (%)
Exhibits 58: Chart on Comparison by Technology
Exhibits 59: Data Table on Comparison by Technology
Exhibits 60: Chart on Bioinformatics - Market size and forecast 2022-2027 ($ billion)
Exhibits 61: Data Table on Bioinformatics - Market size and forecast 2022-2027 ($ billion)
Exhibits 62: Chart on Bioinformatics - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Bioinformatics - Year-over-year growth 2022-2027 (%)
Exhibits 64: Chart on Gene sequencing - Market size and forecast 2022-2027 ($ billion)
Exhibits 65: Data Table on Gene sequencing - Market size and forecast 2022-2027 ($ billion)
Exhibits 66: Chart on Gene sequencing - Year-over-year growth 2022-2027 (%)
Exhibits 67: Data Table on Gene sequencing - Year-over-year growth 2022-2027 (%)
Exhibits 68: Chart on Drug discovery - Market size and forecast 2022-2027 ($ billion)
Exhibits 69: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ billion)
Exhibits 70: Chart on Drug discovery - Year-over-year growth 2022-2027 (%)
Exhibits 71: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%)
Exhibits 72: Chart on Precision molecular diagnostic - Market size and forecast 2022-2027 ($ billion)
Exhibits 73: Data Table on Precision molecular diagnostic - Market size and forecast 2022-2027 ($ billion)
Exhibits 74: Chart on Precision molecular diagnostic - Year-over-year growth 2022-2027 (%)
Exhibits 75: Data Table on Precision molecular diagnostic - Year-over-year growth 2022-2027 (%)
Exhibits 76: Chart on Big data analytics - Market size and forecast 2022-2027 ($ billion)
Exhibits 77: Data Table on Big data analytics - Market size and forecast 2022-2027 ($ billion)
Exhibits 78: Chart on Big data analytics - Year-over-year growth 2022-2027 (%)
Exhibits 79: Data Table on Big data analytics - Year-over-year growth 2022-2027 (%)
Exhibits 80: Market opportunity by Technology ($ billion)
Exhibits 81: Data Table on Market opportunity by Technology ($ billion)
Exhibits 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 83: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 84: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 85: Chart on Geographic comparison
Exhibits 86: Data Table on Geographic comparison
Exhibits 87: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 88: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 89: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 92: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 93: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 96: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 97: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 100: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 101: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 104: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 105: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 111: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 112: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 113: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 114: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 115: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 116: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 117: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 118: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 119: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits 120: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits 121: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 122: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 123: Market opportunity By Geographical Landscape ($ billion)
Exhibits 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 125: Impact of drivers and challenges in 2022 and 2027
Exhibits 126: Overview on Criticality of inputs and Factors of differentiation
Exhibits 127: Overview on factors of disruption
Exhibits 128: Impact of key risks on business
Exhibits 129: Vendors covered
Exhibits 130: Matrix on vendor position and classification
Exhibits 131: Amgen Inc. - Overview
Exhibits 132: Amgen Inc. - Product / Service
Exhibits 133: Amgen Inc. - Key offerings
Exhibits 134: AstraZeneca Plc - Overview
Exhibits 135: AstraZeneca Plc - Product / Service
Exhibits 136: AstraZeneca Plc - Key news
Exhibits 137: AstraZeneca Plc - Key offerings
Exhibits 138: Bristol Myers Squibb Co. - Overview
Exhibits 139: Bristol Myers Squibb Co. - Product / Service
Exhibits 140: Bristol Myers Squibb Co. - Key news
Exhibits 141: Bristol Myers Squibb Co. - Key offerings
Exhibits 142: Catalent Inc. - Overview
Exhibits 143: Catalent Inc. - Business segments
Exhibits 144: Catalent Inc. - Key news
Exhibits 145: Catalent Inc. - Key offerings
Exhibits 146: Catalent Inc. - Segment focus
Exhibits 147: Eli Lilly and Co. - Overview
Exhibits 148: Eli Lilly and Co. - Product / Service
Exhibits 149: Eli Lilly and Co. - Key offerings
Exhibits 150: F. Hoffmann La Roche Ltd. - Overview
Exhibits 151: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 152: F. Hoffmann La Roche Ltd. - Key news
Exhibits 153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 154: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 155: Gilead Sciences Inc. - Overview
Exhibits 156: Gilead Sciences Inc. - Product / Service
Exhibits 157: Gilead Sciences Inc. - Key news
Exhibits 158: Gilead Sciences Inc. - Key offerings
Exhibits 159: Johnson and Johnson Services Inc. - Overview
Exhibits 160: Johnson and Johnson Services Inc. - Business segments
Exhibits 161: Johnson and Johnson Services Inc. - Key news
Exhibits 162: Johnson and Johnson Services Inc. - Key offerings
Exhibits 163: Johnson and Johnson Services Inc. - Segment focus
Exhibits 164: Lonza Group Ltd. - Overview
Exhibits 165: Lonza Group Ltd. - Business segments
Exhibits 166: Lonza Group Ltd. - Key news
Exhibits 167: Lonza Group Ltd. - Key offerings
Exhibits 168: Lonza Group Ltd. - Segment focus
Exhibits 169: Merck and Co. Inc. - Overview
Exhibits 170: Merck and Co. Inc. - Business segments
Exhibits 171: Merck and Co. Inc. - Key news
Exhibits 172: Merck and Co. Inc. - Key offerings
Exhibits 173: Merck and Co. Inc. - Segment focus
Exhibits 174: Novartis AG - Overview
Exhibits 175: Novartis AG - Business segments
Exhibits 176: Novartis AG - Key offerings
Exhibits 177: Novartis AG - Segment focus
Exhibits 178: Pfizer Inc. - Overview
Exhibits 179: Pfizer Inc. - Product / Service
Exhibits 180: Pfizer Inc. - Key news
Exhibits 181: Pfizer Inc. - Key offerings
Exhibits 182: Sanofi SA - Overview
Exhibits 183: Sanofi SA - Business segments
Exhibits 184: Sanofi SA - Key news
Exhibits 185: Sanofi SA - Key offerings
Exhibits 186: Sanofi SA - Segment focus
Exhibits 187: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 188: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 189: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 190: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 191: Thermo Fisher Scientific Inc. - Overview
Exhibits 192: Thermo Fisher Scientific Inc. - Business segments
Exhibits 193: Thermo Fisher Scientific Inc. - Key news
Exhibits 194: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 195: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 196: Inclusions checklist
Exhibits 197: Exclusions checklist
Exhibits 198: Currency conversion rates for US$
Exhibits 199: Research methodology
Exhibits 200: Validation techniques employed for market sizing
Exhibits 201: Information sources
Exhibits 202: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global precision medicine market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biocrates Life Sciences AG, Bristol Myers Squibb Co., Catalent Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., IQVIA Holdings Inc., Johnson and Johnson Services Inc., Lonza Group Ltd., Merck and Co. Inc., Novartis AG, Parexel International Corp., Pfizer Inc., QIAGEN NV, Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing use of artificial intelligence (AI) and machine learning (ML) in precision medicine.'

According to the report, one of the major drivers for this market is the growing prevalence of chronic diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Biocrates Life Sciences AG
  • Bristol Myers Squibb Co.
  • Catalent Inc.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • IQVIA Holdings Inc.
  • Johnson and Johnson Services Inc.
  • Lonza Group Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Parexel International Corp.
  • Pfizer Inc.
  • QIAGEN NV
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Precision Medicine: Global Markets - Product Image

Precision Medicine: Global Markets

  • Report
  • 65 Pages
  • Global
From
Global Precision Medicine Business Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update - Product Image

Global Precision Medicine Business Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update

  • Report
  • 1300 Pages
  • Global
From
Precision Medicine Market Report 2023-2033 - Product Image

Precision Medicine Market Report 2023-2033

  • Report
  • 347 Pages
  • Global
From
Precision Medicine Market by Type (Inhibitors, Monoclonal Antibodies, Cell & Gene Therapy, Antivirals, Antiretroviral), Indication (Oncology, Rare diseases, Hematology, Infectious), End user (Hospitals & Clinics, Home care) & Region - Global Forecast to 2028 - Product Image

Precision Medicine Market by Type (Inhibitors, Monoclonal Antibodies, Cell & Gene Therapy, Antivirals, Antiretroviral), Indication (Oncology, Rare diseases, Hematology, Infectious), End user (Hospitals & Clinics, Home care) & Region - Global Forecast to 2028

  • Report
  • 234 Pages
  • Global
From
Precision Medicine Software Market - A Global and Regional Analysis: Focus on Product Type, Application, End User, and Region - Analysis and Forecast, 2024-2033 - Product Image

Precision Medicine Software Market - A Global and Regional Analysis: Focus on Product Type, Application, End User, and Region - Analysis and Forecast, 2024-2033

  • Report
  • 104 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.